Form 4: Paychex Director Theresa Payton Receives Equity Awards
Insider Transaction Report
Paychex Inc. Director Theresa M. Payton was granted 164 restricted stock units and 670 stock options, aligning her interests with shareholders.
Summary
- Director Theresa M. Payton acquired 164 shares of Paychex Inc. Common Stock as restricted stock units (RSUs) on July 15, 2025, at a price of $0 per share. These RSUs are subject to vesting under the Amended and Restated 2002 Stock Incentive Plan.
- Additionally, Ms. Payton was granted 670 stock options on July 15, 2025, with an exercise price of $140.68 per share. These options become exercisable on July 15, 2026, and expire on July 14, 2035.
- Following these transactions, Ms. Payton beneficially owns a total of 2,075 shares of Common Stock.
- She also beneficially owns 670 stock options with an exercise price of $140.68, 5,082 stock options with an exercise price of $120.86 (exercisable from July 15, 2024, expiring July 14, 2033), and 3,351 stock options with an exercise price of $121.63 (exercisable from July 15, 2025, expiring July 14, 2034).
Sentiment
Score: 7
Explanation: The sentiment is positive as a director received equity awards, which is a beneficial event for the individual and generally viewed as a positive alignment of interests for the company.
Positives
- The acquisition of restricted stock units and stock options for a director aligns their financial interests directly with the long-term performance and shareholder value of Paychex Inc.
- The awards serve as a form of compensation that incentivizes the director to contribute to the company's growth and profitability.
Risks
- The value of the acquired restricted stock units and stock options is subject to the future performance of Paychex Inc.'s stock price, meaning their ultimate value could be lower than anticipated if the stock declines.
- Compliance with Section 16 of the Securities Exchange Act of 1934 requires accurate and timely reporting of insider transactions, and any misstatements or omissions could lead to federal criminal violations.
Future Outlook
The document does not provide forward-looking statements or guidance regarding the company's financial performance or strategic direction, focusing solely on an insider's equity transactions.
Industry Context
This Form 4 filing details an individual insider transaction, which is a routine disclosure for publicly traded companies. It does not provide broader industry context or trends.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Attorney-in-fact for Section 16 Reporting | NA | Prabha S. Bhandari and Robert L. Schrader | 08/01/2024 | Theresa M. Payton granted Limited Power of Attorney to facilitate compliance with Section 16 reporting obligations. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Theresa M. Payton, a Director, granted a Limited Power of Attorney to Prabha S. Bhandari and Robert L. Schrader for the purpose of preparing, executing, acknowledging, delivering, and filing Forms 3, 4, and 5 with the SEC and other relevant entities, related to her Section 16 reporting obligations. | 08/01/2024 | This streamlines the director's compliance with insider trading reporting requirements, ensuring timely and accurate filings. |
Related Party Transactions
- The acquisition of restricted stock units and stock options by Theresa M. Payton, a director of Paychex Inc., constitutes a related party transaction as it involves compensation from the company to a member of its management.
Stakeholder Impact
- Shareholders: The equity awards align the director's financial incentives with shareholder interests, potentially leading to decisions that enhance long-term stock value.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- Vesting of the 164 restricted stock units according to the terms of the Amended and Restated 2002 Stock Incentive Plan.
- The 670 stock options granted on July 15, 2025, will become exercisable on July 15, 2026.
Key Dates
| Date | Description |
|---|---|
| 08/01/2024 | Date Theresa M. Payton executed a Limited Power of Attorney for Section 16 reporting obligations. |
| 07/15/2025 | Transaction date for the acquisition of 164 restricted stock units and 670 stock options. |
| 07/15/2026 | Date the 670 stock options with an exercise price of $140.68 become exercisable. |
| 07/14/2035 | Expiration date for the 670 stock options with an exercise price of $140.68. |
Keywords
Paychex, PAYX, SEC Form 4, Insider Transaction, Stock Award, Restricted Stock Units, Stock Options, Director Compensation, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.